BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33422682)

  • 1. Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19.
    Rencilin CF; Rosy JC; Mohan M; Coico R; Sundar K
    Infect Genet Evol; 2021 Apr; 89():104712. PubMed ID: 33422682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening.
    Waqas M; Haider A; Rehman A; Qasim M; Umar A; Sufyan M; Akram HN; Mir A; Razzaq R; Rasool D; Tahir RA; Sehgal SA
    Biomed Res Int; 2021; 2021():1596834. PubMed ID: 33728324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
    PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
    Dong R; Chu Z; Yu F; Zha Y
    Front Immunol; 2020; 11():1784. PubMed ID: 32849643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
    J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches.
    Marriam S; Afghan MS; Nadeem M; Sajid M; Ahsan M; Basit A; Wajid M; Sabri S; Sajid M; Zafar I; Rashid S; Sehgal SA; Alkhalifah DHM; Hozzein WN; Chen KT; Sharma R
    Front Cell Infect Microbiol; 2023; 13():1134802. PubMed ID: 37293206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
    Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
    Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape and selection of vaccine epitopes in SARS-CoV-2.
    Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
    Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
    Jakhar R; Kaushik S; Gakhar SK
    J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
    Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
    J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
    Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
    J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of
    Elamin Elhasan LM; Hassan MB; Elhassan RM; Abdelrhman FA; Salih EA; Ibrahim H A; Mohamed AA; Osman HS; Khalil MSM; Alsafi AA; Idris AB; Hassan MA
    J Immunol Res; 2021; 2021():8280925. PubMed ID: 34036109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
    Singh J; Malik D; Raina A
    Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach.
    Mahmud S; Rafi MO; Paul GK; Promi MM; Shimu MSS; Biswas S; Emran TB; Dhama K; Alyami SA; Moni MA; Saleh MA
    Sci Rep; 2021 Jul; 11(1):15431. PubMed ID: 34326355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.